NCT02627495

Brief Summary

This study explores the effects transcranial Direct Current Stimulation (tDCS, Soterix ©) on Phantom Limb Pain for patients experiencing chronic phantom limb pain in open-label study design.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 16, 2015

Completed
15 days until next milestone

Study Start

First participant enrolled

December 1, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 11, 2015

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 22, 2019

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 9, 2021

Completed
2 months until next milestone

Results Posted

Study results publicly available

April 23, 2021

Completed
Last Updated

May 11, 2021

Status Verified

April 1, 2021

Enrollment Period

4 years

First QC Date

November 16, 2015

Results QC Date

March 28, 2021

Last Update Submit

April 22, 2021

Conditions

Keywords

maladaptive plasticityLimb amputationphantom limb paintDCSnon-invasive brain stimulation

Outcome Measures

Primary Outcomes (1)

  • Pain as Measured by the Visual Analog Scale

    The VAS is a common assessment used which asks subjects to self-reportedly measure their pain on a visual scale (i.e., unbearable to none). We will use a VAS to determine subjects' pain scores. Subjects will rate their pain from 0 - indicating no pain at all, to 10 - indicating the worst pain felt. This scale is also colored, from green (at 0) to red (at 10), as a visual indicator of pain.

    Change in outcome from baseline to 2-week follow-up (after the last day of stimulation)

Study Arms (1)

tDCS intervention (open label)

EXPERIMENTAL

Subjects will undergo tDCS stimulation

Device: transcranial Direct Current Stimulation (tDCS): (Soterix ©)

Interventions

Subjects will undergo tDCS stimulation. We will use electrodes of 35cm\^2, at an intensity of 2mA on the primary motor cortex contralateral to the amputated limb (or for bilateral amputees contralateral to the most painful side). The subject will undergo stimulation for 20 minutes. The subject will have 5 sessions of stimulation during a 1 week time period.

tDCS intervention (open label)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Able to provide informed consent to participate in the study.
  • Subject is older than 18 years.
  • months of phantom limb pain (experienced regularly for at least once a week) after the amputated limb has completely healed.
  • Average pain of at least 4 on a numeric rating scale in the previous week (NRS; ranging from 0 to 10).
  • If the subject is taking any medications, dosages must be stable for at least 2 weeks prior to the enrollment of the study.

You may not qualify if:

  • Pregnancy or trying to become pregnant in the next 2 months.
  • History of alcohol or drug abuse within the past 6 months as self-reported.
  • Presence of the following contraindication to transcranial direct current stimulation Ferromagnetic metal in the head (e.g., plates or pins, bullets, shrapnel) Implanted head electronic medical devices (e.g., cochlear implants)
  • Head injury resulting in loss of consciousness for at least 30 min or pos-traumatic amnesia for greater than 24 hours, as self-reported
  • Unstable medical conditions (e.g. uncontrolled diabetes, uncompensated cardiac issues, heart failure or chronic obstructive pulmonary disease).
  • Uncontrolled Epilepsy
  • Suffering from severe depression (as defined by a score of \>30 in the Beck Depression Inventory).\*
  • History of unexplained fainting spells or loss of consciousness as self-reported during the last 2 years.
  • History of neurosurgery, as self-reported.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Spaulding Rehabilitation Hospital

Boston, Massachusetts, 02129, United States

Location

MeSH Terms

Conditions

Phantom Limb

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPain, PostoperativePostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsPain

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Results Point of Contact

Title
Prof. Felipe Fregni
Organization
Spaulding Rehabilitation Hospital

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 16, 2015

First Posted

December 11, 2015

Study Start

December 1, 2015

Primary Completion

November 22, 2019

Study Completion

March 9, 2021

Last Updated

May 11, 2021

Results First Posted

April 23, 2021

Record last verified: 2021-04

Locations